Search - tctmd.com

Displaying 541 - 560 of 881

Sort: Relevancy | Date

News Daily News

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

January 01, 2014

News Daily News

Primary PCI Reduces Symptoms vs. Fibrinolysis 5 Years after STEMI

L.A. McKeown

January 01, 2014

News Daily News

La PCI Primaria Reduce los Síntomas frente a la Fibrinolisis 5 Años después de un Cuadro de STEMI

L.A. McKeown

January 01, 2014

News Daily News

Balloon Guide Catheter Improves Acute Stroke Outcomes as Adjunct to Stent Retriever

January 01, 2014

News Daily News

初期研究显示利伐沙班拮抗剂安全、有效

December 30, 2013

News Daily News

Rivaroxaban Antidote Appears Safe, Effective in Early Study

December 30, 2013

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

L.A. McKeown

December 30, 2013

News Daily News

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

L.A. McKeown

December 30, 2013

News Daily News

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

December 30, 2013

Presentation

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Presenter: Ziad Hijazi

December 23, 2013

Presentation

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Presenter: C.T. Ruff

December 15, 2013

Presentation

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Presenter: A. Stazi

December 09, 2013

News Daily News

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

December 05, 2013

News Daily News

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

December 05, 2013

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

Presenter: Eli Lev

December 01, 2013

News Conference News AHA 2013

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Yael L. Maxwell

November 19, 2013

News Conference News AHA 2013

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

November 17, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

Advertisement

Meta-analyses: Novel Anticoagulants Halve Intracranial Hemorrhage vs. Warfarin

Primary PCI Reduces Symptoms vs. Fibrinolysis 5 Years after STEMI

La PCI Primaria Reduce los Síntomas frente a la Fibrinolisis 5 Años después de un Cuadro de STEMI

Balloon Guide Catheter Improves Acute Stroke Outcomes as Adjunct to Stent Retriever

初期研究显示利伐沙班拮抗剂安全、有效

Rivaroxaban Antidote Appears Safe, Effective in Early Study

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Preconditioning May Counteract Platelet Increase Associated with RF Ablation in A-fib

El Preacondicionamiento Contrarrestaría el Aumento Plaquetario secundario a la Ablación RF en el Manejo de la FA

El Antídoto de Rivaroxaban parece Seguro y Eficaz en un Estudio Preliminar

Efficacy and Safety of Dabigatran vs. Warfarin in Relation to Baseline Renal Function in A-fib Patients

Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in A-fib Patients

Effect of Remote Ischemic Preconditioning (IPC) on Platelet Activation and Reactivity Induced by Ablation for A-Fib

Apixaban es Similar a Warfarin en Pacientes con FA sometidos a Cardioversión

Apixaban Comparable to Warfarin for A-fib Patients Undergoing Cardioversion

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Combining Anticoagulant and Antiplatelet Treatment in Patients with Atrial Fibrillation Undergoing PCI - How to Minimize Bleeding and Ischemic Risks?

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Varying Cell Therapy Techniques Demonstrate Safety, Mixed Efficacy at AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content